Regional Victorians To Benefit From Free Access To Glucose Monitoring Devices

Nationals Senator for Victoria, Bridget McKenzie, welcomed news that regional Victorians with type one diabetes will be among those to soon get free access to glucose monitoring devices, thanks to the Liberal-National Government’s $300 million Continuous Glucose Monitoring (CGM) Initiative. The FreeStyle Libre glucose monitoring device measures glucose levels without the use of lancets, test…

Details

Students Encouraged To Claim Assistance Early

Nationals Senator for Victoria, Bridget McKenzie, encourages regional students planning to start tertiary education this year to lodge their claim for Youth Allowance or Austudy now.   Youth Allowance provides financial assistance for eligible young people who pursue further study or an apprenticeship after leaving school. Austudy provides assistance to eligible students and apprentices aged 25…

Details

MEDIA STATEMENT

2 February 2020 Today I have tendered my resignation to the Prime Minister. This decision has obvious implications for my National Party leadership roles so I have informed The Nationals Leader also of my intention to resign my leadership roles. I have been humbled and heartened to be given the opportunity to serve the Australian…

Details

Bridging The Gap: Teaching The Next Generation About What’s On Their Plate

The Liberal and Nationals Government is working to ensure our farming future by investing $5 million to bring kids and farms closer together.  Nationals Senator for Victoria and Minister for Agriculture, Bridget McKenzie, said kids were increasingly removed from directly experiencing life on the land which was a barrier to choosing agriculture as a career and…

Details

New Hope For Breast Cancer Patients In Regional Victoria

Regional Victorians living with advanced breast cancer will have access to an important new treatment option, with the Liberal-National Government listing a life-changing new medicine on the Pharmaceutical Benefits Scheme (PBS). Verzenio® (abemaciclib) is now listed on the PBS for the first time. It will treat non-premenopausal patients with advanced hormone receptor positive human epidermal…

Details